enobosarm

Other names: GTx 024, MK-2866 ester, MK-2866, MK2866 acetate, MK2866 acetate ester, SARM S-22, Ostarine acetic acid ester, 2-[[2-(diethylamino)acetyl]amino]-4-methyl-5-(2-methylsulfanylethyl)-1H-pyrrole-3- carboxamide, Ostarinyl acetate, Ostarine-O-Acetate, MK2866, GTx-024, (S)-Ostarine, Ostarine, Ostarine acetate ester, GTx024, (2S)-3-(4-Cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide, MK2866 acetic acid ester, S22, propanamide, 3-(4-cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-, (2S)-, S-22

Classifications: 6000

Reasons for prohibition: - WADA S1: Anabolic Agents (source) - Unapproved Drug - FDA Statement

References: - {'title': 'NIH NCATS Inxight Drugs entry: Enobosarm', 'url': 'https://drugs.ncats.io/drug/O3571H3R8N'} - {'title': 'FDA warns against using SARMs in body-building products', 'url': 'https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products'}

Reason: WADA S1: Anabolic Agents; Unapproved drug; FDA statement: SARMs

Label terms: ["(2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide"]

Searchable name: enobosarm

GUID: 86d79e58-87cc-4a94-81a3-516b69d8c421

Added: 2026-01-01T00:09:47.312568+00:00

Updated: {"_seconds": 1744128270, "_nanoseconds": 242000000}